Börskollen - Aktier, fonder och ekonominyheter
BörskollenFör dig med koll på börsen
•Vår app: Sveriges bästa börsapp? 4,6 / 5 i betyg – och helt gratis!

Pressmeddelanden från Orion

 Bevaka pressreleaser
Kurs från TradingView
StartNyheterPressreleaserRiktkurserInsynshandelBlankningAnalyserBloggarVideosPodcasts

The Board of Directors of Orion Corporation decided on a new plan period for the Long-term Incentive program for the company’s key persons

The Board of Directors of Orion Corporation decided on a new plan period for the Long-term Incentive program for the company’s key persons

GlobeNewswire • 12 feb 12:12

Notice to the Annual General Meeting of Orion Corporation

Notice to the Annual General Meeting of Orion Corporation

GlobeNewswire • 12 feb 11:05

Orion Group Financial Statement Release January–December 2025

Orion Group Financial Statement Release January–December 2025

GlobeNewswire • 12 feb 11:00

62,752 Orion Corporation A shares converted into B shares

62,752 Orion Corporation A shares converted into B shares

GlobeNewswire • 03 feb 08:00

Orion publishes Financial Statement Release for 2025 and holds a webcast on 12 February 2026

Orion publishes Financial Statement Release for 2025 and holds a webcast on 12 February 2026

GlobeNewswire • 30 jan 08:30

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.

GlobeNewswire • 20 jan 07:30

182,827 Orion Corporation A shares converted into B shares

182,827 Orion Corporation A shares converted into B shares

GlobeNewswire • 16 jan 08:30

Recommendation by the Orion Nomination Committee on the proposals to be presented to the 2026 Annual General Meeting

Recommendation by the Orion Nomination Committee on the proposals to be presented to the 2026 Annual General Meeting

GlobeNewswire • 15 jan 15:30

Orion updates time estimate for the potential related to the annual Nubeqa® net sales recorded by Orion

Orion updates time estimate for the potential related to the annual Nubeqa® net sales recorded by Orion

GlobeNewswire • 14 jan 15:00

Inside information: Orion provides outlook for 2026 and estimates that the annual Nubeqa® net sales recorded by Orion has potential to exceed EUR 1 billion in the future

Inside information: Orion provides outlook for 2026 and estimates that the annual Nubeqa® net sales recorded by Orion has potential to excee...

GlobeNewswire • 14 jan 07:30

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.

GlobeNewswire • 13 jan 15:30

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.

GlobeNewswire • 12 jan 14:00

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.

GlobeNewswire • 09 jan 15:00

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.

GlobeNewswire • 08 jan 14:00

Orion Pharma announces the initiation of TEADES Phase 2 trial of ODM-212 in Malignant Pleural Mesothelioma (MPM) and Epithelioid Hemangioendothelioma (EHE)

Orion Pharma announces the initiation of TEADES Phase 2 trial of ODM-212 in Malignant Pleural Mesothelioma (MPM) and Epithelioid Hemangioend...

GlobeNewswire • 08 jan 11:00

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.

GlobeNewswire • 07 jan 15:30

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.

GlobeNewswire • 07 jan 07:30

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.

GlobeNewswire • 31 dec 2025 12:00

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.

GlobeNewswire • 30 dec 2025 13:00

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.

GlobeNewswire • 23 dec 2025 15:00

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.

GlobeNewswire • 15 dec 2025 13:30

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.

GlobeNewswire • 09 dec 2025 16:30

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.

GlobeNewswire • 08 dec 2025 14:30

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.

GlobeNewswire • 05 dec 2025 16:00

Inside information: Orion to receive EUR 180 million milestone and updates full-year outlook for 2025

Inside information: Orion to receive EUR 180 million milestone and updates full-year outlook for 2025

GlobeNewswire • 03 dec 2025 08:00

71,498 Orion Corporation A shares converted into B shares

71,498 Orion Corporation A shares converted into B shares

GlobeNewswire • 27 nov 2025 08:00

Orion receives award for international growth from the President of the Republic of Finland

Orion receives award for international growth from the President of the Republic of Finland

GlobeNewswire • 14 nov 2025 12:30

Orion Group Interim Report January–September 2025

Orion Group Interim Report January–September 2025

GlobeNewswire • 28 okt 2025 11:00

49,164 Orion Corporation A shares converted into B shares

49,164 Orion Corporation A shares converted into B shares

GlobeNewswire • 24 okt 2025 08:00

Orion and Abzena announce exclusive commercial license for Abzena’s antibody

Orion and Abzena announce exclusive commercial license for Abzena’s antibody

GlobeNewswire • 23 okt 2025 14:30

Orion publishes Interim Report for January–September 2025 and holds a webcast on 28 October 2025

Orion publishes Interim Report for January–September 2025 and holds a webcast on 28 October 2025

GlobeNewswire • 14 okt 2025 10:15

Orion’s phase 2 study of ODM-105 in insomnia did not meet primary goal 

Orion’s phase 2 study of ODM-105 in insomnia did not meet primary goal 

GlobeNewswire • 30 sep 2025 12:00

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.

GlobeNewswire • 30 sep 2025 08:00

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.

GlobeNewswire • 26 sep 2025 15:30

80,802 Orion Corporation A shares converted into B shares

80,802 Orion Corporation A shares converted into B shares

GlobeNewswire • 19 sep 2025 08:00

337,000 Orion Corporation A shares converted into B shares

337,000 Orion Corporation A shares converted into B shares

GlobeNewswire • 20 aug 2025 08:00

Orion Corporation: Managers’ transactions – Juhani Kankaanpää

Orion Corporation: Managers’ transactions – Juhani Kankaanpää

GlobeNewswire • 08 aug 2025 08:30

Orion Corporation: Managers’ transactions – Satu Ahomäki

Orion Corporation: Managers’ transactions – Satu Ahomäki

GlobeNewswire • 04 aug 2025 15:10

Darolutamide receives EU approval in third indication for patients with advanced prostate cancer

Darolutamide receives EU approval in third indication for patients with advanced prostate cancer

GlobeNewswire • 21 jul 2025 09:30

Orion Group Half-Year Financial Report January–June 2025

Orion Group Half-Year Financial Report January–June 2025

GlobeNewswire • 18 jul 2025 11:00

Orion Corporation’s financial reporting and Annual General Meeting in 2026

Orion Corporation’s financial reporting and Annual General Meeting in 2026

GlobeNewswire • 18 jul 2025 08:30

Inside information: Orion upgrades full-year outlook for 2025

Inside information: Orion upgrades full-year outlook for 2025

GlobeNewswire • 09 jul 2025 12:00

Orion publishes Half-Year Financial Report for January–June 2025 and holds a webcast on 18 July 2025

Orion publishes Half-Year Financial Report for January–June 2025 and holds a webcast on 18 July 2025

GlobeNewswire • 04 jul 2025 08:00

141,959 Orion Corporation A shares converted into B shares

141,959 Orion Corporation A shares converted into B shares

GlobeNewswire • 23 jun 2025 08:30

CHMP recommends third indication for darolutamide for patients with advanced prostate cancer

CHMP recommends third indication for darolutamide for patients with advanced prostate cancer

GlobeNewswire • 20 jun 2025 12:30

Orion and Glykos announce the extension of their research collaboration and licensing agreement for the development of next-generation ADCs

Orion and Glykos announce the extension of their research collaboration and licensing agreement for the development of next-generation ADCs

GlobeNewswire • 17 jun 2025 08:00

U.S. FDA approves third indication of darolutamide for patients with advanced prostate cancer

U.S. FDA approves third indication of darolutamide for patients with advanced prostate cancer

GlobeNewswire • 03 jun 2025 22:30

Orion announces agreement with Shilpa Medicare for Recombinant Human Albumin for European market

Orion announces agreement with Shilpa Medicare for Recombinant Human Albumin for European market

GlobeNewswire • 23 maj 2025 11:40

Orion to host Capital Markets Day today, 22 May 2025, in Helsinki

Orion to host Capital Markets Day today, 22 May 2025, in Helsinki

GlobeNewswire • 22 maj 2025 09:15

Orion’s collaborator, MSD, expands clinical development program for opevesostat to women’s cancers

Orion’s collaborator, MSD, expands clinical development program for opevesostat to women’s cancers

GlobeNewswire • 21 maj 2025 06:30

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.

GlobeNewswire • 08 maj 2025 15:30

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.

GlobeNewswire • 07 maj 2025 16:00

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.

GlobeNewswire • 06 maj 2025 17:00

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.

GlobeNewswire • 05 maj 2025 16:00

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.

GlobeNewswire • 02 maj 2025 14:15

Orion Corporation: Managers’ transactions – Eija Ronkainen

Orion Corporation: Managers’ transactions – Eija Ronkainen

GlobeNewswire • 02 maj 2025 10:45

Orion Corporation: Managers’ transactions – Ari Lehtoranta

Orion Corporation: Managers’ transactions – Ari Lehtoranta

GlobeNewswire • 02 maj 2025 10:45

Orion Corporation: Managers’ transactions – Kari Jussi Aho

Orion Corporation: Managers’ transactions – Kari Jussi Aho

GlobeNewswire • 02 maj 2025 10:45

Orion Corporation: Managers’ transactions – Veli-Matti Mattila

Orion Corporation: Managers’ transactions – Veli-Matti Mattila

GlobeNewswire • 02 maj 2025 10:45

Orion Corporation: Managers’ transactions – Henrik Stenqvist

Orion Corporation: Managers’ transactions – Henrik Stenqvist

GlobeNewswire • 02 maj 2025 10:45

Orion Corporation: Managers’ transactions – Maziar Mike Doustdar

Orion Corporation: Managers’ transactions – Maziar Mike Doustdar

GlobeNewswire • 02 maj 2025 10:45

Orion Corporation: Managers’ transactions – Karen Lykke Sørensen

Orion Corporation: Managers’ transactions – Karen Lykke Sørensen

GlobeNewswire • 02 maj 2025 10:45

Orion Corporation: Managers’ transactions – Hilpi Rautelin

Orion Corporation: Managers’ transactions – Hilpi Rautelin

GlobeNewswire • 02 maj 2025 10:45

301,521 Orion Corporation A shares converted into B shares

301,521 Orion Corporation A shares converted into B shares

GlobeNewswire • 02 maj 2025 08:00

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.

GlobeNewswire • 25 apr 2025 16:20

Orion and Criceto Announce a License Agreement for APORON®, an Innovative Apomorphine Spray to Treat OFF Episodes in Parkinson’s Disease

Orion and Criceto Announce a License Agreement for APORON®, an Innovative Apomorphine Spray to Treat OFF Episodes in Parkinson’s Disease

GlobeNewswire • 25 apr 2025 08:00

Composition of the Nomination Committee of Orion Corporation

Composition of the Nomination Committee of Orion Corporation

GlobeNewswire • 24 apr 2025 10:00

Orion Group Interim Report January–March 2025

Orion Group Interim Report January–March 2025

GlobeNewswire • 23 apr 2025 11:00

Invitation to Orion’s Capital Markets Day on 22 May 2025

Invitation to Orion’s Capital Markets Day on 22 May 2025

GlobeNewswire • 22 apr 2025 08:00

Statutory negotiations at Orion's R&D unit in Turku, Finland have been concluded

Statutory negotiations at Orion's R&D unit in Turku, Finland have been concluded

GlobeNewswire • 15 apr 2025 09:00

The Helsinki Court of Appeal sentenced a member of Orion's Board of Directors to a fine for a securities market information offence

The Helsinki Court of Appeal sentenced a member of Orion's Board of Directors to a fine for a securities market information offence

GlobeNewswire • 10 apr 2025 12:15

Orion publishes Interim Report for January–March 2025 and holds a webcast on 23 April 2025

Orion publishes Interim Report for January–March 2025 and holds a webcast on 23 April 2025

GlobeNewswire • 09 apr 2025 12:30

Orion Corporation: Organising meeting of the Board of Directors

Orion Corporation: Organising meeting of the Board of Directors

GlobeNewswire • 03 apr 2025 15:25

Decisions taken by Orion Corporation’s Annual General Meeting on 3 April 2025

Decisions taken by Orion Corporation’s Annual General Meeting on 3 April 2025

GlobeNewswire • 03 apr 2025 15:20

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.

GlobeNewswire • 21 mar 2025 14:00

Pharmaceutical industry delivers value proposition to Finnish Government: billions to be invested by 2030 

Pharmaceutical industry delivers value proposition to Finnish Government: billions to be invested by 2030 

GlobeNewswire • 21 mar 2025 12:00

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.

GlobeNewswire • 20 mar 2025 14:30

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.

GlobeNewswire • 19 mar 2025 13:30

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.

GlobeNewswire • 17 mar 2025 16:15

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.

GlobeNewswire • 14 mar 2025 14:30

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.

GlobeNewswire • 13 mar 2025 15:45

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.

GlobeNewswire • 12 mar 2025 15:15

Orion Group Financial Statement documents 2024 and Remuneration Report published

Orion Group Financial Statement documents 2024 and Remuneration Report published

GlobeNewswire • 11 mar 2025 10:15

Orion Corporation: Managers’ transactions – Olli Huotari

Orion Corporation: Managers’ transactions – Olli Huotari

GlobeNewswire • 11 mar 2025 08:00

Orion Corporation: Managers’ transactions – Juhani Kankaanpää

Orion Corporation: Managers’ transactions – Juhani Kankaanpää

GlobeNewswire • 11 mar 2025 08:00

Orion Corporation: Managers’ transactions – Outi Vaarala

Orion Corporation: Managers’ transactions – Outi Vaarala

GlobeNewswire • 11 mar 2025 08:00

Orion Corporation: Managers’ transactions – Liisa Hurme

Orion Corporation: Managers’ transactions – Liisa Hurme

GlobeNewswire • 11 mar 2025 08:00

Orion Corporation: Managers’ transactions – Satu Ahomäki

Orion Corporation: Managers’ transactions – Satu Ahomäki

GlobeNewswire • 11 mar 2025 08:00

Orion Corporation: Managers’ transactions – René Lindell

Orion Corporation: Managers’ transactions – René Lindell

GlobeNewswire • 11 mar 2025 08:00

Orion Corporation: Managers’ transactions – Niclas Lindstedt

Orion Corporation: Managers’ transactions – Niclas Lindstedt

GlobeNewswire • 11 mar 2025 08:00

Orion Corporation: Managers’ transactions – Hao Pan

Orion Corporation: Managers’ transactions – Hao Pan

GlobeNewswire • 11 mar 2025 08:00

Orion Corporation: Managers’ transactions – Julia Macharey

Orion Corporation: Managers’ transactions – Julia Macharey

GlobeNewswire • 11 mar 2025 08:00

Orion Corporation: Transfer of 191,911 own B shares on 10 March 2025

Orion Corporation: Transfer of 191,911 own B shares on 10 March 2025

GlobeNewswire • 10 mar 2025 18:00

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.

GlobeNewswire • 10 mar 2025 16:00

Orion to open new Biologics R&D Centre in Cambridge, UK in 2025 to support global growth strategy, considers reorganizing some work in Turku

Orion to open new Biologics R&D Centre in Cambridge, UK in 2025 to support global growth strategy, considers reorganizing some work in Turku

GlobeNewswire • 10 mar 2025 10:45

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.

GlobeNewswire • 05 mar 2025 16:00

Orion and Aiforia extend collaboration to preclinical study evaluations

Orion and Aiforia extend collaboration to preclinical study evaluations

GlobeNewswire • 05 mar 2025 08:00

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.

GlobeNewswire • 05 mar 2025 07:30

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.

GlobeNewswire • 03 mar 2025 15:30

Orion Corporation: Managers’ transactions – Outi Vaarala

Orion Corporation: Managers’ transactions – Outi Vaarala

GlobeNewswire • 28 feb 2025 16:45